GW is a Cambridge-based biopharmaceutical company that researches and markets cannabinoid medicine for the treatment of LGS and Dravet syndrome... Read more
GW is a Cambridge-based biopharmaceutical company that researches and markets cannabinoid medicine for the treatment of LGS and Dravet syndrome... Read more